SEI Investments’s Exagen XGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$529K Sell
65,091
-43,914
-40% -$282K ﹤0.01% 2609
2026
Q2
$507K Sell
109,005
-135,235
-55% -$509K ﹤0.01% 2631
2026
Q1
$733K Buy
244,240
+126,235
+107% +$488K ﹤0.01% 2505
2025
Q4
$717K Buy
+118,005
New +$1.07M ﹤0.01% 2332

Other funds holding XGN

SEI Investments's XGN Position: Q3 2026 in Review

SEI Investments reduced its Exagen (XGN) stake by 40% in Q3 2026, selling an estimated $282K and leaving 65,091 shares worth $529K. The position accounts for ﹤0.01% of the portfolio, ranked #2609.

SEI Investments first reported a position in XGN in Q4 2025 and has held it in 4 quarters since. The position peaked at $733K in Q1 2026. 78 funds tracked by Wall St. Rank hold XGN as of Q3 2026.

  • SEI Investments held 65,091 shares of Exagen worth $529K as of Q3 2026.
  • SEI Investments sold 43,914 Exagen shares in Q3 2026, an estimated $282K.
  • Exagen made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #2609 holding.
  • SEI Investments first reported a position in Exagen in Q4 2025 and has held it in 4 quarters since.
  • SEI Investments's Exagen position peaked at $733K in Q1 2026.
  • 78 funds tracked by Wall St. Rank held Exagen as of Q3 2026.

Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.